Valery V. Smirnov - Search Results

Year	Number of Results
2010	1
2016	1
2017	2
2018	1
2019	1
2020	2
2021	3
2022	1
2023	1
2024	0

1

MicroRNAs as novel biomarkers for rivaroxaban therapeutic drug monitoring.

Rytkin E, Bure IV, Bochkov PO, Akmalova KA, Mirzaev KB, Cherniaeva MS, Ostroumova OD, Smirnov VV, Grishina EA, Saribekian AG, Sychev IN, Sychev DA. Rytkin E, et al. Among authors: smirnov vv. Drug Metab Pers Ther. 2021 Aug 13;37(1):41-46. doi: 10.1515/dmpt-2021-0118. Drug Metab Pers Ther. 2021. PMID: 35385896

2

MicroRNAs as novel biomarkers for rivaroxaban therapeutic drug monitoring.

Rytkin E, Bure IV, Bochkov PO, Akmalova KA, Mirzaev KB, Cherniaeva MS, Ostroumova OD, Smirnov VV, Grishina EA, Saribekian AG, Sychev IN, Sychev DA. Rytkin E, et al. Among authors: smirnov vv. Drug Metab Pers Ther. 2021 Aug 13. doi: 10.1515/dmdi-2021-0118. Online ahead of print. Drug Metab Pers Ther. 2021. PMID: 34390638

3

Affinity Capture Elution (ACE) ELISA Method Development and Validation for Novel RPH-104 Drug Immunogenicity Evaluation.

Kolganova MA, Melnik EV, Fisher EN, Smirnov VV, Vlasov AM, Gegechkori VI, Shulga NA, Shokhin IE, Ramenskaya GV. Kolganova MA, et al. Among authors: smirnov vv. Biomedicines. 2022 Oct 29;10(11):2750. doi: 10.3390/biomedicines10112750. Biomedicines. 2022. PMID: 36359270 Free PMC article.

4

Coherent Anti-Stokes Raman Scattering Measurements of Time and Length Scales of Temperature Fluctuations in a Turbulent Flame.

Kobtsev VD, Kozlov DN, Kostritsa SA, Orlov SN, Smirnov VV, Volkov SY. Kobtsev VD, et al. Among authors: smirnov vv. Appl Spectrosc. 2023 May;77(5):482-490. doi: 10.1177/00037028231160797. Epub 2023 Feb 24. Appl Spectrosc. 2023. PMID: 36792938

5

CYP3A subfamily activity affects the equilibrium concentration of Phenazepam^® in patients with anxiety disorders and comorbid alcohol use disorder.

Zastrozhin MS, Skryabin VY, Sorokin AS, Petukhov AE, Smirnov VV, Pankratenko EP, Grishina EA, Ryzhikova KA, Panov AS, Savchenko LM, Bryun EA, Sychev DA. Zastrozhin MS, et al. Pharmacogenomics. 2020 May;21(7):449-457. doi: 10.2217/pgs-2019-0071. Epub 2020 Apr 27. Pharmacogenomics. 2020. PMID: 32336193

6

Study of the Acute Toxicity of a New Dosage Form of Naloxone Hydrochloride for Intranasal Administration.

Bariev EA, Krasnyuk II, Anurova MN, Bakhrushina EO, Smirnov VV, Bardakov AI, Demina NB, Krasnyuk II Jr. Bariev EA, et al. Among authors: smirnov vv. Drug Res (Stuttg). 2020 Jan;70(1):23-25. doi: 10.1055/a-0899-4948. Epub 2019 Sep 16. Drug Res (Stuttg). 2020. PMID: 31525817

7

The influence of CYP3A5 polymorphisms on haloperidol treatment in patients with alcohol addiction.

Zastrozhin MS, Grishina EA, Ryzhikova KA, Smirnov VV, Savchenko LM, Bryun EA, Sychev DA. Zastrozhin MS, et al. Pharmgenomics Pers Med. 2017 Dec 28;11:1-5. doi: 10.2147/PGPM.S144503. eCollection 2018. Pharmgenomics Pers Med. 2017. PMID: 29343979 Free PMC article.

8

A Use of Tritium-Labeled Peat Fulvic Acids and Polyphenolic Derivatives for Designing Pharmacokinetic Experiments on Mice.

Badun GA, Chernysheva MG, Zhernov YV, Poroshina AS, Smirnov VV, Pigarev SE, Mikhnevich TA, Volkov DS, Perminova IV, Fedoros EI. Badun GA, et al. Among authors: smirnov vv. Biomedicines. 2021 Nov 29;9(12):1787. doi: 10.3390/biomedicines9121787. Biomedicines. 2021. PMID: 34944604 Free PMC article.

9

Genotyping and phenotyping of CYP2D6 and CYP3A isoenzymes in patients with alcohol use disorder: correlation with haloperidol plasma concentration.

Sychev DA, Zastrozhin MS, Miroshnichenko II, Baymeeva NV, Smirnov VV, Grishina EA, Ryzhikova KA, Mirzaev KB, Markov DD, Skryabin VY, Snalina NE, Nosikova PG, Savchenko LM, Bryun EA. Sychev DA, et al. Among authors: smirnov vv. Drug Metab Pers Ther. 2017 Sep 26;32(3):129-136. doi: 10.1515/dmpt-2017-0021. Drug Metab Pers Ther. 2017. PMID: 28787271

10

The correlation between CYP2D6 isoenzyme activity and haloperidol efficacy and safety profile in patients with alcohol addiction during the exacerbation of the addiction.

Sychev DA, Zastrozhin MS, Smirnov VV, Grishina EA, Savchenko LM, Bryun EA. Sychev DA, et al. Pharmgenomics Pers Med. 2016 Sep 14;9:89-95. doi: 10.2147/PGPM.S110385. eCollection 2016. Pharmgenomics Pers Med. 2016. PMID: 27695358 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

11 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Results by year